SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-13-074383
Filing Date
2013-10-07
Accepted
2013-10-07 17:01:09
Documents
1
Period of Report
2013-10-07

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2743
  Complete submission text file 0001104659-13-074383.txt   4093
Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address
McGuigan Christopher (Reporting) CIK: 0001412484 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55020 | Film No.: 131139654

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations